Apico-aortic conduit for severe hypertrophic cardiomyopathy: sudden death despite conduit patency 31 years

Gianantonio Nappi1, Giovanni Dialetto, Marisa De Feo

  • 1Department of Cardiothoracic and Respiratory Sciences, Second University of Naples, c/o V. Monaldi Hospital, via L Bianchi, Naples, Italy.

Insights

Apico-aortic valved conduit offers long-term symptom relief for select hypertrophic cardiomyopathy (HCM) patients when myectomy is not feasible. However, it does not prevent late-stage disease progression.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Medical Case Study

Background:

  • Hypertrophic cardiomyopathy (HCM) presents challenges in treatment, particularly when severe ventricular hypertrophy obstructs the outflow tract.
  • Conventional myectomy may not be suitable for all HCM patients, necessitating alternative surgical approaches.

Observation:

  • A young female patient with severe, diffuse HCM underwent apico-aortic valved conduit surgery due to an absent outflow tract cavity.
  • Long-term follow-up over 31 years revealed sustained symptom relief and successful pregnancies.
  • Imaging confirmed excellent conduit patency without bioprosthetic calcification.

Findings:

  • The apico-aortic conduit provided 30 years of symptom-free living without medication.
  • Despite surgical success, the patient's HCM progressed to a dilative phase.
  • Sudden death occurred while awaiting advanced heart failure management.

Implications:

  • Apico-aortic valved conduit may be a viable option for carefully selected HCM patients unsuitable for myectomy.
  • While effective for obstruction relief, this approach does not preclude the eventual development of end-stage heart failure.
  • This case highlights the potential for durable palliation but underscores the progressive nature of HCM.